Oral sirolimus in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis; Tuberous sclerosis
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2015 New trial record
- 10 Sep 2015 Results published in the Journal of the American Academy of Dermatology.